QuidelOrtho Corp SEC filings QDEL

QuidelOrtho Corp has 502 filings in SEC EDGAR's recent list, going back to Jan 31, 2022. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 28, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 27, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations, officer or director change). The company's fiscal year ends on January 1.

Form Description Filed Period
SD Specialized disclosure (conflict minerals) May 11, 2026 —
SD Specialized disclosure (conflict minerals) May 22, 2025 —
SD Specialized disclosure (conflict minerals) May 30, 2024 —
SD Specialized disclosure (conflict minerals) May 31, 2023 —
8-K12B/A Filing Aug 10, 2022 May 27, 2022
8-K12B Filing May 27, 2022 May 27, 2022
EFFECT Filing Apr 11, 2022 —
CORRESP Letter to the SEC Apr 8, 2022 —
CORRESP Letter to the SEC Apr 4, 2022 —
UPLOAD Letter from the SEC Mar 30, 2022 —
CORRESP Letter to the SEC Mar 14, 2022 —
UPLOAD Letter from the SEC Mar 1, 2022 —

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
In Vitro & In Vivo Diagnostic Substances (SIC 2835)
Listed as
QDEL (Nasdaq)
Fiscal year ends
January 1
Headquarters
San Diego, CA
SEC filer status
Large accelerated filer
SEC CIK
1906324
Former names
Coronado Topco, Inc. (until Apr 11, 2022)

Other In Vitro & In Vivo Diagnostic Substances companies

All 21 In Vitro & In Vivo Diagnostic Substances companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.